Berton Wang is a China Associate in the Corporate practice and is based in the firm’s Beijing office. His practice focuses on initial public offerings, mergers and acquisitions, and private equity transactions.
Mr. Wang passed the bar examination in China in 2012, but does not hold a current practicing certificate. Mr. Wang is fluent in English and Mandarin.
First Vaccine Company Listed on the Hong Kong Stock Exchange as CanSinoBIO Debuts
March 28, 2019
Weimob Inc., the largest WeChat-based third-party service provider, Completes HK$756 Million Hong Kong IPO
January 15, 2019
Ascletis Pharma Debuts as First Biotechnology Hong Kong IPO under New Listing Rules
August 01, 2018